BBOT
BridgeBio Oncology Therapeutics, Inc.
3.90$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +0.2% | +130.3% | +58,304.2% | +130.6% | |
| – | – | – | -50.5% | +21,721.0% | |
| – | – | – | +579.1% | +21,910.4% | |
| – | – | – | – | +24,959.8% | |
| – | – | – | – | – | |
| – | +2.3% | +138.2% | +1,339.6% | +553.3% | |
| – | +2.3% | +138.2% | -52.7% | +18,587.0% | |
| – | +16.6% | +62.6% | – | – | |
| – | – | – | +434.6% | -55.3% | |
| – | – | – | – | +117.8% | |
| – | – | – | – | – | |
| – | +0.0% | +0.0% | -99.9% | +241,276.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.